J. C. Murray

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Yvette Drew, Jonathan A. Ledermann, Geoff Hall et al. · British Journal of Cancer · 2016 · 161 citations · Full text

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

Claire Schwab, Sarra Ryan, Lucy Chilton et al. · Blood · 2016 · 132 citations · Full text

Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

Aiste McCormick, Peter Donoghue, Michelle Dixon et al. · Clinical Cancer Research · 2016 · 87 citations · Full text

Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System

Karen E. Parrish, Ling Cen, J. C. Murray et al. · Molecular Cancer Therapeutics · 2015 · 86 citations · Full text

Pharmacotherapy, High-grade Gliomas, Glioma +18

The identification of probable sarcopenia in early old age based on the SARC-F tool and clinical suspicion: findings from the 1946 British birth cohort

Richard Dodds, J. C. Murray, Siân Robinson et al. · European Geriatric Medicine · 2020 · 62 citations · Full text